Skip to main content

Lupin Implements Acceliant Platform for BA/BE studies

Objective- Lupin was looking for a robust platform for their clinical studies which has a best in breed user interface and is also cost effective.

Major challenges:-

  1. Manage individual tools for normal phase of CT and BA/BE trial.
  2. For each trial, separate discussion for pricing and maintain individual documents. Also, they will have to be cautious with the number of pages and subjects.
  3. We’re outsourcing their current technology, wanted an easy to use platform for internal team


  1. No restriction (unlimited pages, sites, subjects and 100 trials/year)
  2. Feature rich (So many features facilitates the data collection and review).
  3. Can create trial independently.
  4. If required, can derive the workflow in Acceliant like blood sample collection time entry.

You might also like...

eCRF development in clinical trials: A smarter approach to build studies

A Fortune 500 pharmaceuticals company sought an EDC solution for a late phase immunology and infectious disease target audience. Acceliant developed a scalable platform to address the quantum of data as the trial progressed.

Continue Reading >

Watch: How we add value

Want to know more? Talk to us.

Contact us+1-408-387-5800